GlassScriptPhysician profile
Sreevani Thota
NPI 1912232695
$4,118.33
in general payments reported to CMS, 2019-2025
32 companies · $676 in 2025
The $676 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $749 · 2021: $1,357 · 2022: $607 · 2024: $354 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $680.57 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $663.51 | 2019-2025 | Breztri, Farxiga, Lokelma |
| Novo Nordisk INC | $617.77 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Janssen Pharmaceuticals, INC | $249.54 | 2020-2021 | |
| Abbvie INC. | $202.49 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $189.25 | 2019-2022 | |
| Exact Sciences Corporation | $180.80 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $172.49 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $167.84 | 2021-2025 | |
| Mannkind Corporation | $151.82 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $118.95 | 2019-2022 | |
| Renalytix Ai, INC. | $77.34 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Amarin Pharma, INC. | $68.48 | 2019-2021 | |
| Astellas Pharma US INC | $58.32 | 2020-2022 | |
| Horizon Therapeutics Plc | $56.16 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $51.10 | 2024-2025 | Evenity, Prolia, Prolia |
| Novartis Pharmaceuticals Corporation | $45.03 | 2019-2021 | |
| Boston Scientific Corporation | $43.44 | 2020-2025 | Wavewriter Alpha Prime 16 |
| E.R. Squibb & Sons, L.L.C. | $40.07 | 2022-2024 | Camzyos |
| Abbott Laboratories | $38.80 | 2022-2024 | Freestyle Libre 3 |
| Dexcom, INC. | $33.34 | 2024 | Dexcom G6 Transmitter |
| Azurity Pharmaceuticals, INC. | $33.06 | 2025 | Horizant |
| Allergan, INC. | $28.59 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.35 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $24.84 | 2020-2021 | |
| Bausch Health US, LLC | $15.39 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.00 | 2021 | |
| Cashflow Solutions, LLC | $13.76 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Nabriva Therapeutics, Plc | $13.63 | 2021 | |
| Currax Pharmaceuticals LLC | $13.25 | 2022 | |
| Ironwood Pharmaceuticals, INC | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sreevani Thota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.